Experimental drug reverses severe fatty liver disease by repairing the gut
An experimental drug called DT-109 reversed severe fatty liver disease in animal studies by repairing the gut and preventing harmful toxins from damaging the liver. The discovery could open the door…
Read the full articleYou might also wanna read
Experimental drug reverses severe fatty liver disease by repairing the gut
An experimental drug called DT-109 reversed severe fatty liver disease in animal studies by repairing the gut and preventing harmful toxins
Drug candidate treats severe fatty liver disease by protecting the gut in animal models
Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving gut health, accor
New drug candidate treats severe fatty liver disease by improving gut health
Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving ...
Microbial metabolite restores liver health by targeting PPARα and lipid metabolism through the gut-liver axis
Chronic liver diseases, including liver steatosis and fibrosis, are driven in part by dysregulation of PPARα and lipid metabolism. These dis
journals.asm.org·10mo agoNew research identifies potential treatment target in fatty liver disease
Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study
Metabolic dysfunction–associated steatohepatitis exacerbated by Clostridium perfringens–derived ammonia is attenuated by tripeptide DT-109
The global prevalence of metabolic dysfunction–associated steatohepatitis (MASH) is rising, driven by a complex interplay of metabolic distu
Comments
Sign in to join the conversation.
No comments yet. Be the first.